A prospective audit of regional anaesthesia failure in 5080 Caesarean sections.
Anaesthesia for Caesarean section was audited over a 5 year period: 5080 cases were performed using spinal 63%, epidural top-up 26%, combined spinal-epidural 5% and primary general anaesthesia 5%. The rate of general anaesthesia conversion of regional anaesthesia was 0.8% for elective and 4.9% for emergency Caesarean section compared to Royal College of Anaesthetists targets of 1% and 3%. The rate of conversion of regional to general anaesthesia in category 1 Caesarean section was 20%. A total of 8% of women had general anaesthesia when both primary general and conversion of regional anaesthesia were combined. The rate of failure to achieve a pain-free operation was 6% with spinals, 24% with epidural top-up and 18% with combined spinal-epidural. Besides the type of anaesthesia and operative urgency, other factors associated with pre-operative failure of regional anaesthesia included body mass index, no previous Caesareans, and indication for Caesarean of acute fetal distress or maternal medical condition. Inadequacy of pre-operative anaesthetic block and duration of surgery were important risk factors for intra-operative failure. For spinal anaesthesia, use of a spinal opioid was associated with less pre-operative failure. For epidural top-up anaesthesia, lower epidural top-up volume was associated with less pre-operative failure, and use of adrenaline was associated with both less pre-operative and intra-operative failure. The rate of serious adverse incidents was 1 : 126 with general anaesthesia and 1 : 501 with regional anaesthesia.
Kinsella
S M
SM
Department of Anaesthesia, St Michael's Hospital, Bristol BS2 8EG, UK. stephen.kinsella@ubht.nhs.uk
D000765:Anesthesia, Conduction / Q000009:adverse effects; D000768:Anesthesia, General; D000773:Anesthesia, Obstetrical / Q000009:adverse effects / Q000379:methods*; D002585:Cesarean Section; D004630:Emergencies; D005260:Female; D006801:Humans; D008485:Medical Audit; D011247:Pregnancy; D011446:Prospective Studies; D017211:Treatment Failure